Список литературы

1. Brosman S. Penile Cancer Workup.//https://emedicine.medscape.com/article/446554-workup#c4.

2. Hakenberg O.W., , Minhas S. et al. Guidelines on Penile Cancer. EAU 2017: 20 - 21.

3. Каприн А.Д., Старинский В.В., Петрова Г.В. Злокачественные новообразования в России в 2015 году (заболеваемость и смертность). М.: МНИОИ им. П.А. Герцена (филиал ФГБУ "НМИРЦ" Минздрава России), 2017.

4. WHO Classification of Tumours of the Urinary System and Male Genital Organs. (ed. H Moch et al). IARC, Lyon, 2016.

5. Cubilla A.L., Reuter V., Velazquez E. et al. Histologic classification of penile carcinoma and its relation to outcome in 61 patients with primary resection. International Journal of Surgical Pathology. 2001; 9(2): 111 - 120.

6. Brierley J.D., Gospodorawicz M.K., Wittekind C. TNM Classification of Malignant Tumours, 8^th ed. International Union Against Cancer, Wiley-Blackwell, 2016: 188 - 9.

7. Халафьян Э.А. Органосохраняющее лечение больных раком полового члена. Дисс. канд. мед. наук. М. 2003.

8. Falanga A., Marchetti M., Vignoli A. Coagulation and cancer: biological and clinical aspects //Journal of Thrombosis and Haemostasis. - 2013. - T. 11. - N. 2. - C. 223 - 233.

9. Loreto M.F. et al. Coagulation and cancer: implications for diagnosis and management //Pathology & Oncology Research. - 2000. - T. 6. - N. 4. - C. 301 - 312.

10. Kvolik S. et al. An overview of coagulation disorders in cancer patients //Surgical oncology. - 2010. - T. 19. - N. 1. - C. e33 - e46.

11. JEFF A. SIMERVILLE, M.D., WILLIAM C. MAXTED, M.D., and JOHN J. PAHIRA, M.D., Urinalysis: A Comprehensive Review Am Fam Physician. 2005 Mar 15; 71(6): 1153 - 1162.

12. Правосудова Н.А. и др. Особенности послеоперационных осложнений в отделении онкоурологии и онкогинекологии //Медицинский альманах. - 2016. - N. 3 (43).

13. В.М. Гельфанд Инфекционные осложнения у онкологических больных//Практическая онкология. - 2009. - Т. 10. - N 3. - стр. 141 - 146.

14. Lont A.P., Besnard A.P., Gallee M.P. et al. A comparison of physical examination and imaging in determining the extent of primary penile carcinoma. BJU International. 2003; 91(6): 493 - 5.

15. Kayes O., Minhas S., Allen C. et al. The role of magnetic resonance imaging in the local staging of penile cancer. European Urology. 2007; 51: 1313 - 8.

16. Lucchesi F.R., Reis R.B., Faria E.F. et al. Incremental value of MRI for preoperative penile cancer staging. Journal of Magnetic Resonance Imaging. 2017; 45(1): 118 - 124.

17. Andipa E., Liberopoulos K., Asvestis C. Magnetic resonance imaging and ultrasound evaluation of penile and testicular masses. World Journal of Urology. 2004; 22(5): 382 - 391.

18. Van Poppel H., N.A. Watkin, S. Osanto, L. Moonen, A. Horwich, V. Kataja Penile Carcinoma: ESMO Clinical Practice Guidelines Ann Oncol 2013; 24 (Suppl 6): vi115 - vi124.

19. Kroon BK et al: Ultrasonography-guided fine-needle aspiration cytology before sentinel node biopsy in patients with penile carcinoma. BJU Int 2005; 95: 517. http://www.ncbi.nlm.nih.gov/pubmed/15705071.

20. Saisorn I et al: Fine-needle aspiration cytology predicts inguinal lymph node metastasis without antibiotic pretreatment in penile carcinoma. BJU Int 2006; 97:1225. http://www.ncbi.nlm.nih.gov/pubmed/16686716.

21. Ornellas A.A., Seixas A.L., Marota A. et al. Surgical treatment of invasive squamous Cell carcinoma of the penis: retrospective analysis of 350 cases. Journal Urology. 1994; 151(5): 1244 - 1249.

22. Baumgarten A., Chipollini J., Yan S. et al. Penile Sparing Surgery for Penile Cancer: A Multicenter International Retrospective Cohort. Journal Urology. 2018; 199(5): 1233 - 1237.

23. Kamel M.H., Bissada N., Warford R. et al. Organ Sparing Surgery for Penile Cancer: A Systematic Review. Journal Urology. 2017; 198(4): 770 - 779.

24. Gonzaga-Silva L.F., Lima G.R.M., Tavares J.M. et al. Locally advanced penile carcinoma: classic emasculation or testis-sparing surgery? International Brazilian Journal of Urology. 2012; 38(6): 750 - 759.

25. Peters P.C. Penis, urethra, trauma and fistulas. Journal Urology. 1989; 142(6): 1654 - 1658.

26. Minhas S., Kayes O., Hegarty P. et al. What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU International. 2005; 96(7): 1040 - 1043

27. Korzeniowski Martin Arthur, Juanita Mary Crook Contemporary role of radiotherapy in the management of penile cancer Transl Androl Urol. 2017 Oct; 6(5): 855 - 867.

28. NCCN guidelines version 2.2019 Penile Cancer

29. Meijer R.P., Boon T.A., van Venrooij G.E., Wijburg C.J. Long-term follow-up after laser therapy for penile carcinoma. Urology. 2007; 69(4): 759 - 62.

30. Bandieramonte G., Colecchia M., Mariani L. et al. Peniscopically controlled CO2 laser excision for conservative treatment of in situ and T1 penile carcinoma: report on 224 patients. European Urology. 2008; 54(4): 875 - 82.

31. Deen K., Burdon-Jones D. Imiquimod in the treatment of penile intraepithelial neoplasia: An update. Australas J Dermatol. 2017; 58(2): 86 - 92.

32. Hu X., Huang J., Wen S. et al. Comparison of efficacy between brachytherapy and penectomy in patients with penile cancer: a meta-analysis. Oncotarget. 2017; 8(59): 100469 - 100477.

33. Azrif M., Logue J.P., Swindell R. et al. External-beam radiotherapy in T1 - 2 N0 penile carcinoma. Clinical Oncology (The Royal College of Radiologists). 2006; 18(4): 320 - 5.

34. Makarewicz Roman, Andrzej Lebioda, Joanna Terlikiewicz Interstitial brachytherapy for penile cancer: the experience of Oncology Centre in Bydgoszcz. J Contemp Brachytherapy. 2010 Dec; 2(4): 157 - 159.

35. Pagliaro L.C., Crook J. Multimodality therapy in penile cancer: when and which treatments? World Journal of Urology. 2009; 27(2): 221 - 225.

36. Crook J., Ma C., Grimard L. Radiation therapy in the management of the primary penile tumor: an update. World Journal of Urology. 2009; 27(2): 189 - 96.

37. Montana G.S., Thomas G.M., Moore D.H. et al. Preoperative chemo-radiation for carcinoma of the vulva with N2/N3 nodes: a gynecologic oncology group study. International Journal of Radiation Oncology, Biology, Physics. 2000; 48(4): 1007 - 13.

38. Ajani J.A., Winter K.A., Gunderson L.L. et al. Fluorouracil, mitomycin, and radiotherapy vs fluorouracil, cisplatin, and radiotherapy for carcinoma of the anal canal: a randomized controlled trial. JAMA. 2008; 299(16): 1914 - 21.

39. Solsona E., Iborra I., Rubio J. et al. Prospective validation of the association of local tumor stage and grade as a predictive factor for occult lymph node micrometastasis in patients with penile carcinoma and clinically negative inguinal lymph nodes. Journal of Urology. 2001; 165(5): 1506 - 9.

40. Theodorescu D., Russo P., Zhang Z.F. et al. Outcomes of initial surveillance of invasive squamous cell carcinoma of the penis and negative nodes. Journal of Urology. 1996; 155(5): 1626 - 31.

41. Leijte J.A., Kroon B.K., Olmos R.A. et al. Reliability and safety of current dynamic sentinel node biopsy for penile carcinoma. European Urology. 2007; 52(1): 170 - 7.

42. Ficarra V., Galfano A. Should the dynamic sentinel node biopsy (DSNB) be considered the gold standard in the evaluation of lymph node status in patients with penile carcinoma? European Urology. 2007; 52(1): 17 - 9.

43. Spiess P.E., Hernandez M.S., Pettaway C.A. Contemporary inguinal lymph node dissection: minimizing complications. World Journal of Urology. 2009; 27(2): 205 - 12.

44. Protzel C., Alcaraz A., Horenblas S. et al. Lymphadenectomy in the surgical management of penile cancer. European Urology. 2009; 55(5): 1075 - 88.

45. Lopes A., Rossi B.M., Fonseca F.P., Morini S. Unreliability of modified inguinal lymphadenectomy for clinical staging of penile carcinoma. Cancer. 1996; 77(10): 2099 - 102.

46. Pizzocaro G., Piva L., Bandieramonte G., Tana S. Up-to-date management of carcinoma of the penis. European Urology. 1997; 32(1): 5 - 15.

47. Zargar-Shoshtari K., Djajadiningrat R., Sharma P. et al. Establishing Criteria for Bilateral Pelvic Lymph Node Dissection in the Management of Penile Cancer: Lessons Learned from an International Multicenter Collaboration. Journal of Urology. 2015; 194(3): 696 - 701.

48. Pedrick T.J., Wheeler W., Riemenschneider H. Combined modality therapy for locally advanced penile squamous cell carcinoma. American Journal of Clinical Oncology. 1993; 16(6): 501 - 5.

49. Eliason M., Bowen G., Bowen A. et al. Primary treatment of verrucous carcinoma of the penis with fluorouracil, cis-diamino-dichloro-platinum, and radiation therapy. Arch Dermatol. 2009; 145(8): 950 - 2.

50. Chhabra A., Schwartz D., Leaf A., et al. Neoadjuvant concurrent chemoradiation for curative treatment of penile squamous cell carcinoma. Case Rep Oncol Med. 2014; 2014: 479376.

51. Sharma P., Djajadiningrat R., Zargar-Shoshtari K. et al. Adjuvant chemotherapy is associated with improved overall survival in pelvic node-positive penile cancer after lymph node dissection: a multi-institutional study. Urology Oncology. 2015; 33(11): 496.e17 - 23.

52. Bermejo C., Busby J.E., Spiess P.E. et al. Neoadjuvant chemotherapy followed by aggressive surgical consolidation for metastatic penile squamous cell carcinoma. Journal of Urology. 2007; 177(4): 1335 - 8.

53. Pagliaro L.C., Williams D.L., Daliani D. et al. Neoadjuvant paclitaxel, ifosfamide, and cisplatin chemotherapy for metastatic penile cancer: a phase II study. Journal of Clinical Oncology. 2010; 28(24): 3851 - 7.

54. Lughezzani G., Catanzaro M, Torelli T. et al. The relationship between characteristics of inguinal lymph nodes and pelvic lymph node involvement in penile squamous cell carcinoma: a single institution experience. Journal of Urology. 2014; 191(4): 977 - 82.

55. Lont A.P., Kroon B.K., Gallee M.P. et al. Pelvic lymph node dissection for penile carcinoma: extent of inguinal lymph node involvement as an indicator for pelvic lymph node involvement and survival. Journal of Urology. 2007; 177(3): 947 - 52.

56. Di Lorenzo G., Buonerba C., Federico P. et al. Cisplatin and 5-fluorouracil in inoperable, stage IV squamous cell carcinoma of the penis. BJU International. 2012; 110(11 Pt B): E661 - 6.

57. Haas G.P., Blumenstein B.A., Gagliano R.G. et al. Cisplatin, methotrexate and bleomycin for the treatment of carcinoma of the penis: a Southwest Oncology Group study. Journal of Urology. 1999; 161(6): 1823 - 5.

58. Di Lorenzo G., Federico P., Buonerba C. et al. Paclitaxel in pretreated metastatic penile cancer. final results of a phase 2 study. European Urology. 2011; 60: 1280 - 1284.

59. Wu J., Cheng K., Yuan L. et al. Recurrent Penile Squamous Cell Carcinoma Successfully Treated With Cetuximab, Chemotherapy, and Radiotherapy. Clinical Genitourinary Cancer. 2016 Feb; 14(1): e135 - 7.

60. Luo W.X., He J.P., Li X., Liu J.Y. Neoadjuvant chemotherapy with cetuximab for locally advanced penile cancer. J Cancer Res Ther. 2015; 11(4): 1041.

61. Sitompul A.P., Prapiska F.F., Warli S.M. Evaluation of Paclitaxel, Ifosfamide, and Cisplatin (TIP) Regimen on Penile Cancer in Adam Malik Medan: A Single Center 2 Years of Experience //Open access Macedonian journal of medical sciences. - 2019. - T. 7. - N. 7. - C. 1148.

62. Joerger M., Warzinek T., Klaeser B. et al. Major tumor regression after paclitaxel and carboplatin polychemotherapy in a patient with advanced penile cancer. Urology. 2004; 63(4): 778 - 80.

63. Carthon B.C. et al. Epidermal growth factor receptor targeted therapy in locally advanced or metastatic squamous cell carcinoma of the penis //BJU international. - 2014. - T. 113. - N. 6. - C. 871 - 877.

64. Winters B.R., Kearns J.T., Holt S.K. et al. Is there a benefit to adjuvant radiation in stage III penile cancer after lymph node dissection? Findings from the National Cancer Database. Urology Oncology. 2018; 36(3): 92.e11 - 92.e16.

65. Robinson R., Marconi L., MacPepple E. et al. Risks and Benefits of Adjuvant Radiotherapy After Inguinal Lymphadenectomy in Node-positive Penile Cancer: A Systematic Review by the European Association of Urology Penile Cancer Guidelines Panel. European Urology. 2018; 74(1): 76 - 83.

66. Pond G.R., Milowsky M.I., Kolinsky M.P. et al. Concurrent chemoradiotherapy for men with locally advanced penile squamous cell carcinoma. Clinical Genitourinary Cancer. 2014; 12(6): 440 - 6.

67. Silver JK, Baima J: Cancer prehabilitation: an opportunity to decrease treatment-related morbidity, increase cancer treatment options, and improve physical and psychological health outcomes. Am J Phys Med Rehabil 2013, 92(8): 715 - 727.

68. Tsimopoulou I, Pasquali S, Howard R, Desai A, Gourevitch D, Tolosa I, Vohra R: Psychological Prehabilitation Before Cancer Surgery: A Systematic Review. Ann Surg Oncol 2015 Dec; 22(13): 4117 - 23. doi: 10.1245/s10434-015-4550-z. Epub 2015 Apr 14.

69. Swarm R, Abernethy AP, Anghelescu DL et al. NCCN Adult Cancer Pain. Adult cancer pain. J Natl Compr Canc Netw. 2010; 8: 1046 - 1086.

70. Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M, Ripamonti CI, Committee EG: Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol 2018; 29(Suppl 4): iv166 - iv191.

71. Committee. NMA: Topic: The Diagnosis and Treatment of Lymphedema. Position Statement of the National Lymphedema Network. In., 2011. P. 1 - 19.

72. Segal R, Zwaal C, Green E, Tomasone JR, Loblaw A, Petrella T: Exercise for People with Cancer Guideline Development G: Exercise for people with cancer: a systematic review. Curr Oncol 2017; 24(4): e290 - e315.

73. Boyd C, Crawford C, Paat CF, Price A, Xenakis L, Zhang W: Evidence for Massage Therapy Working G: The Impact of Massage Therapy on Function in Pain Populations - A Systematic Review and Meta-Analysis of Randomized Controlled Trials: Part II, Cancer Pain Populations. Pain Med 2016; 17(8): 1553 - 1568.

74. Stout NL, Baima J, Swisher AK, Winters-Stone KM, Welsh J: A Systematic Review of Exercise Systematic Reviews in the Cancer Literature (2005 - 2017). PM R 2017, 9(9S2): S347 - S384.

75. Hu M, Lin W: Effects of exercise training on red blood cell production: implications for anemia. Acta Haematol 2012; 127(3): 156 - 164.

76. Mustian KM, Alfano CM, Heckler C, Kleckner AS, Kleckner IR, Leach CR, Mohr D, Palesh OG, Peppone LJ, Piper BF et al: Comparison of Pharmaceutical, Psychological, and Exercise Treatments for Cancer-Related Fatigue: A Meta-analysis. JAMA Oncol 2017; 3(7): 961 - 968.

77. Kleckner IR, Kamen C, Gewandter JS, Mohile NA, Heckler CE, Culakova E, Fung C, Janelsins MC, Asare M, Lin PJ et al: Effects of exercise during chemotherapy on chemotherapy-induced peripheral neuropathy: a multicenter, randomized controlled trial. Support Care Cancer 2018; 26(4): 1019 - 1028.

78. Lee JM, Look RM, Turner C, Gardiner SK, Wagie T, Douglas J, Sorenson L, Evans L, Kirchner S, Dashkoff C et al: Low-level laser therapy for chemotherapy-induced peripheral neuropathy. Journal of Clinical Oncology 2012; 30(15_suppl): 9019 - 9019.

79. Rick O, von Hehn U, Mikus E, Dertinger H, Geiger G: Magnetic field therapy in patients with cytostatics-induced polyneuropathy: A prospective randomized placebo-controlled phase-III study. Bioelectromagnetics 2017; 38(2): 85 - 94.

80. Kilinc M, Livanelioglu A, Yildirim SA, Tan E: Effects of transcutaneous electrical nerve stimulation in patients with peripheral and central neuropathic pain. J Rehabil Med 2014; 46(5): 454 - 460.

81. Oberoi S, Zamperlini-Netto G, Beyene J, Treister NS, Sung L: Effect of prophylactic low level laser therapy on oral mucositis: a systematic review and meta-analysis. PLoS One 2014, 9(9): e107418.

82. Westphal JG, Schulze PC: Exercise training in cancer related cardiomyopathy. J Thorac Dis 2018; 10(Suppl 35): S4391 - S4399.

83. Ross M, Fischer-Cartlidge E: Scalp Cooling: A Literature Review of Efficacy, Safety, and Tolerability for Chemotherapy-Induced Alopecia. Clin J Oncol Nurs 2017; 21(2): 226 - 233.

84. Leijte J.A. et al. Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. European Urology. 2008; 54: 161.

85. Chung T.S. et al. Synchronous penile metastasis from a rectal carcinoma //International journal of colorectal disease. - 2008. - T. 23. - N. 3. - C. 333 - 334.

86. Lestrade L. et al. Radiochemotherapy and brachytherapy could be the standard treatment for anal canal cancer in elderly patients? A retrospective single-centre analysis //Medical Oncology. - 2013. - T. 30. - N. 1. - C. 402.